Donald Barry Boyd, MD, MS | Authors

Avelumab Maintenance for Urothelial Carcinoma: Real-World Evidence

December 22, 2021

Daniel Petrylak, MD and Donald Barry Boyd, MD, MS, examine real-world data presented in the recent publication, “Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice.”